We are live on
!
Find out more
VCM
Versant Capital Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
34.21%
This Fund
S&P 500
This Quarter
Est. Return
+13.52%
1 Year Est. Return
+34.21%
3 Year Est. Return
+82.39%
5 Year Est. Return
+89.4%
10 Year Est. Return
+245.39%
AUM
$1.12B
AUM Growth
+$101M
(+10%)
Cap. Flow
+$19.1M
Cap. Flow
% of AUM
1.71%
Top 10 Holdings %
Top 10 Hldgs %
31.56%
Holding
2,873
New
96
Increased
1,181
Reduced
859
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXUV
Dimensional US Vector Equity ETF
DXUV
|
+$8.37M |
| 2 |
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
|
+$7.66M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$6.75M |
| 4 |
DXIV
Dimensional International Vector Equity ETF
DXIV
|
+$4.35M |
| 5 |
Dimensional Emerging Markets Value ETF
DFEV
|
+$2.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$2.11M |
| 2 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$2.02M |
| 3 |
Vanguard Total Stock Market ETF
VTI
|
+$1.88M |
| 4 |
CoreCivic
CXW
|
+$1.84M |
| 5 |
Apple
AAPL
|
+$1.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.06% |
| 2 | Financials | 7.05% |
| 3 | Industrials | 6.04% |
| 4 | Consumer Discretionary | 4.74% |
| 5 | Healthcare | 4.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
KB Financial Group
KB
$41.7B
| $7.56K | ﹤0.01% |
72
+47
| +188% | +$4.97K |
|
2327
Caesars Entertainment
CZR
$6.08B
| $7.54K | ﹤0.01% |
250
+43
| +21% | +$1.21K |
|
2328
Oil States International
OIS
$524M
| $7.5K | ﹤0.01% |
937
| – | – |
|
2329
Bloomin' Brands
BLMN
$687M
| $7.5K | ﹤0.01% |
820
-496
| -38% | -$3.61K |
|
2330
The Ensign Group
ENSG
$10.1B
| $7.37K | ﹤0.01% |
46
-11
| -19% | -$1.94K |
|
|
TRTX
2331
TPG RE Finance Trust
TRTX
$667M
| $7.35K | ﹤0.01% |
878
| – | – |
|
2332
Shinhan Financial Group
SHG
$33.7B
| $7.34K | ﹤0.01% |
116
+57
| +97% | +$3.74K |
|
|
PRSU
2333
Pursuit Attractions and Hospitality Inc
PRSU
$1.44B
| $7.33K | ﹤0.01% |
131
| – | – |
|
2334
Cytokinetics
CYTK
$11.1B
| $7.33K | ﹤0.01% |
86
-42
| -33% | -$3.02K |
|
2335
Healthcare Services Group
HCSG
$1.55B
| $7.29K | ﹤0.01% |
297
+50
| +20% | +$1.06K |
|
2336
Power Integrations
POWI
$3.68B
| $7.29K | ﹤0.01% |
87
-57
| -40% | -$4.11K |
|
2337
Aura Biosciences
AURA
$740M
| $7.26K | ﹤0.01% |
1,023
-438
| -30% | -$3.13K |
|
2338
iShares US Energy ETF
IYE
$1.75B
| $7.25K | ﹤0.01% |
128
+1
| +0.8% | +$61 |
|
2339
Global X MLP ETF
MLPA
$2.28B
| $7.22K | ﹤0.01% |
136
| – | – |
|
2340
O-I Glass
OI
$1.39B
| $7.21K | ﹤0.01% |
749
+564
| +305% | +$5.31K |
|
|
BBNX
2341
Beta Bionics
BBNX
$721M
| $7.18K | ﹤0.01% |
458
+159
| +53% | +$1.89K |
|
2342
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.5B
| $7.16K | ﹤0.01% |
87
| – | – |
|
|
TIC
2343
TIC Solutions Inc
TIC
$1.6B
| $7.14K | ﹤0.01% |
883
-602
| -41% | -$5.08K |
|
2344
Pentair
PNR
$10.3B
| $7.13K | ﹤0.01% |
93
-270
| -74% | -$21.4K |
|
2345
iShares US Infrastructure ETF
IFRA
$4.65B
| $7.12K | ﹤0.01% |
113
| – | – |
|
2346
Korro Bio
KRRO
$163M
| $7.1K | ﹤0.01% |
539
-152
| -22% | -$1.89K |
|
2347
Energy Transfer Partners
ET
$70.3B
| $7.08K | ﹤0.01% |
371
+21
| +6% | +$407 |
|
2348
HDFC Bank
HDB
$120B
| $7.08K | ﹤0.01% |
274
+164
| +149% | +$4.11K |
|
2349
Citizens Financial Services
CZFS
$358M
| $7.03K | ﹤0.01% |
97
| – | – |
|
2350
Kodak
KODK
$796M
| $7.01K | ﹤0.01% |
758
+639
| +537% | +$7.01K |
|
Similar funds
FLAM
AIM
MTCM
CNC
NOSC
RIM
ACG
C
Versant Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Versant Capital Management held 2,873 positions worth $1.12B, up 10% from $1.01B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Versant Capital Management's Q2 2026 filing shows 96 new, 1,181 increased, 859 reduced and 128 closed positions. Its largest new stake was AstraZeneca: 7,263 shares worth $1.36M. The largest sale was iShares 3-7 Year Treasury Bond ETF, an estimated $2.11M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Industrials.
- Versant Capital Management's largest Q2 2026 buy was AstraZeneca: 7,263 shares worth $1.36M.
- Versant Capital Management added most to Dimensional US Vector Equity ETF in Q2 2026, an estimated $8.37M increase.
- Versant Capital Management's biggest Q2 2026 reduction was iShares 3-7 Year Treasury Bond ETF, cutting an estimated $2.11M.
- Versant Capital Management fully exited iShares 5-10 Year Investment Grade Corporate Bond ETF in Q2 2026, selling an estimated $2.02M.
- Versant Capital Management's ten largest holdings make up 32% of its $1.12B portfolio in Q2 2026.
- Versant Capital Management opened 96 new positions and closed 128 in Q2 2026.
- Versant Capital Management's portfolio value rose 10% quarter-over-quarter to $1.12B.
Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.